Cone-Beam CT Dose: Why CTDI Falls Short

Q: Why does CTDI underestimate cone-beam CT dose?

The standard CTDI chamber is 100 mm long, but many cone-beam CT (CBCT) systems use a beam width far wider than 100 mm. The chamber cannot capture the full scatter tails of a wide beam, so a CTDI measurement misses dose that falls outside the chamber and underreports the true central dose.

Q: Is kerma-area product a good dose metric for CBCT?

Kerma-area product (KAP, also called dose-area product or DAP) is a practical and widely displayed metric for C-arm and dental CBCT systems. It does not by itself give organ or effective dose, but with validated conversion coefficients it supports patient dose estimation and protocol tracking.

Q: Does CBCT require medical physics testing and QC?

Yes. CBCT systems used clinically should have acceptance testing, periodic performance evaluation, and a routine quality-control program appropriate to the platform — interventional C-arm, dental, image-guided radiotherapy, or dedicated extremity — performed or overseen by a qualified medical physicist.

Q: How can CBCT dose be reduced without losing diagnostic value?

Collimate to the smallest clinically adequate field of view, choose the lowest resolution and frame rate that answers the clinical question, use anatomy- and age-specific protocols, enable available iterative or model-based reconstruction, and review reference dose levels periodically against peers.

Introduction

Cone-beam CT dose is one of the most commonly mismeasured quantities in diagnostic imaging, because the metric most people reach for — CTDI — was never designed for a wide cone beam. Conventional CT dose index methodology assumes a relatively narrow beam scanned helically through a 100 mm pencil ionization chamber. Many cone-beam CT (CBCT) systems irradiate a volume tens of centimeters wide in a single rotation, so a 100 mm chamber simply cannot capture the full dose profile. The result is a number that looks authoritative but understates the dose actually delivered. ¹²

CBCT now appears across the imaging enterprise: interventional and surgical C-arms, dental and maxillofacial units, dedicated extremity and weight-bearing scanners, breast CBCT, and the kilovoltage imaging subsystems on radiotherapy linear accelerators. Each platform displays a different dose surrogate, and each has its own appropriate measurement method. Treating them all as if they were a multidetector CT is a recipe for both under- and over-estimating patient dose. ²³

This guide explains why CTDI breaks down for wide cone beams, what the AAPM Task Group 111 equilibrium-dose approach measures instead, how kerma-area product fits in, and how to build a defensible CBCT dose and quality-control program. DRPS supports facilities across Florida, Maryland, Virginia, Washington DC, California, and Nevada with CT physics testing and broader medical physics consulting.

Topic Explanation

What is cone-beam CT?

Cone-beam CT is a tomographic acquisition that uses a divergent cone (or wide fan) of X-rays and a two-dimensional flat-panel detector to reconstruct a volume from projections acquired over a single partial or full rotation. Unlike multidetector CT (MDCT), which builds a volume from many thin slices acquired helically, CBCT captures the whole volume of interest in one sweep. That geometry gives CBCT excellent spatial resolution and a compact, often mobile, form factor, but it also changes the dose physics.

Key terms used throughout this guide:

CTDI (computed tomography dose index) — the integral of a single-rotation dose profile measured in a standard 100 mm pencil chamber, normalized to beam width. The workhorse metric for MDCT.
Equilibrium dose ( $D_{e q}$ ) — the maximum accumulated central dose reached when a phantom is long enough that scatter contributions saturate. The basis of the AAPM TG-111 approach. ¹
Kerma-area product (KAP / DAP) — the air kerma integrated over the beam area, independent of distance. The native metric displayed by most C-arm and dental CBCT systems.
Field of view (FOV) — the imaged volume. In CBCT, FOV selection is one of the strongest dose levers available to the operator.

Why the metric depends on the platform

There is no single "CBCT dose number." A dedicated breast CBCT, a surgical C-arm spin, a small-FOV dental scan, and a linac cone-beam acquisition are physically different irradiations. What unites them is geometry — a wide beam and an area detector — and that geometry is exactly what makes the legacy CTDI framework unreliable when the nominal beam width approaches or exceeds the 100 mm chamber length. ¹²

The practical consequence is that a qualified medical physicist must match the measurement method to the platform, then translate the result into something clinically meaningful: a reference level, an organ-dose estimate, or a protocol-optimization target. For the underlying MDCT metrics that CBCT departs from, see our primer on CTDIvol and DLP dose metrics.

Key Technical Principles

Where CTDI comes from — and where it breaks

For a single axial rotation, the conventional CTDI measured with a 100 mm pencil chamber is defined as the integral of the dose profile $D (z)$ along the rotation axis, normalized to the nominal beam width $N \cdot T$ :

CTDI_{100} = \frac{1}{N \cdot T} \int_{- 50 mm}^{+ 50 mm} D (z) d z

The weighted CTDI combines central and peripheral measurements in the CTDI phantom to approximate an average cross-sectional dose:

CTDI_{w} = \frac{1}{3} CTDI_{100, center} + \frac{2}{3} CTDI_{100, periphery}

This framework works well when the beam is narrow relative to the 100 mm integration limits. It fails for CBCT for two reasons. First, when the nominal beam width exceeds 100 mm, a large fraction of the dose profile — including scatter tails — falls outside the chamber, so the integral is truncated. Second, many CBCT acquisitions are partial-rotation or stationary-beam, which violates the helical, uniformly-rotating assumptions baked into CTDIvol. ¹²

The TG-111 equilibrium-dose approach

AAPM Task Group 111 reframed CT dosimetry around the approach to equilibrium. Instead of forcing a wide beam into a 100 mm chamber, a small thimble or point detector is placed at the center of a long phantom, and the accumulated dose is measured as a function of phantom (or scan) length $L$ . As $L$ increases, scatter contributions accumulate until they saturate at the equilibrium dose $D_{e q}$ . The rise toward equilibrium can be written as a function $H (L)$ that approaches unity for long scans: ¹

H (L) = \frac{D _{L} ( 0 )}{D _{e q}}, L \to \infty lim H (L) = 1

The strength of this approach is that it characterizes the real cumulative central dose of a wide or stationary beam without truncation. A comparison study of kilovoltage CBCT on radiotherapy units found that the TG-111 full-scatter method measured the highest — and most physically complete — central dose, while the legacy CTDI method consistently measured the lowest, confirming CTDI's limitations for CBCT. ⁴

Kerma-area product for C-arm and dental systems

For interventional C-arm and dental CBCT, the practically displayed quantity is the kerma-area product. Because $P_{K A}$ is the product of air kerma and beam area, it is conserved along the beam axis (ignoring attenuation in air) and is therefore independent of source-to-detector distance. A region-specific conversion coefficient $k$ converts $P_{K A}$ into an estimate of effective dose:

E = k \cdot P_{K A}

where $k$ depends on anatomy, beam quality, and patient size and must be drawn from validated tables rather than assumed.

Comparing the dose metrics

Method	What it measures	Best suited to	Key limitation
CTDI / CTDIvol (100 mm chamber)	Integrated single-rotation dose normalized to beam width	Narrow-beam CBCT and MDCT-style acquisitions	Truncates the dose profile when beam width approaches or exceeds 100 mm ¹²
AAPM TG-111 equilibrium dose	Cumulative central dose at approach to equilibrium in a long phantom	Wide-beam and stationary-beam CBCT; research-grade characterization ¹⁴	Requires a long phantom and point detector; more involved than routine CTDI
Cone-Beam Dose Index (CBDI)	CTDI-style metric adapted for wide beams using existing equipment	Clinical CBCT where full TG-111 setup is impractical ⁴	Approximation to TG-111; still relies on standard phantoms
Kerma-area product (KAP/DAP)	Air kerma integrated over beam area	C-arm, dental, and fluoroscopically guided CBCT	Not an organ or effective dose without validated conversion coefficients

A worked CTDIw example

Suppose acceptance testing on a narrow-beam CBCT protocol that still fits within the 100 mm chamber yields a measured central value of 8.0 mGy and a peripheral value of 12.0 mGy in the body phantom. The weighted CTDI is:

CTDI_{w} = \frac{1}{3} (8.0) + \frac{2}{3} (12.0) = 2.67 + 8.0 \approx 10.7 mGy

For a single full rotation with pitch equal to one, $CTDI_{v o l} = CTDI_{w} / pitch \approx 10.7$ mGy. This is a defensible number only because the beam fits the chamber. If the same platform offered a 16 cm wide single-rotation mode, this CTDI measurement would understate the central dose and a TG-111 or CBDI approach would be required instead. ¹⁴ Published C-arm CBCT work illustrates the range of real organ doses: a study of pediatric body C-arm CBCT on a modern system reported the majority of organ doses below 1 mGy for optimized acquisitions, while a methodology comparison on radiotherapy CBCT measured pelvis central doses of roughly 21–22 mGy using the TG-111 full-scatter method. ³⁴

Clinical Impact

Getting CBCT dose right is not an academic exercise — it changes protocol decisions, justification, and how facilities defend their imaging to accreditors and patients. Because CBCT often serves image guidance (needle placement, surgical navigation, radiotherapy setup) rather than primary diagnosis, the dose can be incurred repeatedly across a single episode of care. A C-arm spin during a long interventional case, or a daily setup CBCT across a multi-week radiotherapy course, accumulates in ways a single-study mindset misses.

Field-of-view selection is the dominant lever. In dental and maxillofacial CBCT, effective dose scales strongly with FOV and resolution: a small-FOV, standard-resolution endodontic scan can deliver a small fraction of the dose of a large-FOV, high-resolution craniofacial acquisition. The clinical takeaway is that "one CBCT" can mean very different doses depending on how the operator sets it up.

Pediatric and repeated-exposure populations deserve particular attention. The same physics that makes CBCT compact also makes it easy to over-scan a child or to repeat a spin when a single optimized acquisition would suffice. The principles in our guide to pediatric CT dose optimization apply directly to CBCT, and for any patient who is or may be pregnant, the considerations in fetal dose in medical imaging should be part of the justification conversation.

Practical Optimization Tips

A practical CBCT dose program combines correct measurement with disciplined protocol management.

1. Match the metric to the platform

Narrow-beam CBCT that fits the 100 mm chamber: CTDI/CTDIvol may be acceptable.
Wide-beam or stationary-beam CBCT: use TG-111 equilibrium-dose or a validated CBDI approximation. ¹⁴
C-arm and dental CBCT: track KAP/DAP and reference air kerma, and convert to dose estimates only with validated coefficients.

2. Collimate aggressively

The single most effective dose-reduction step in CBCT is restricting the field of view to the clinically necessary volume. Smaller FOV reduces both primary and scatter dose and frequently improves image quality by reducing scatter-induced artifacts.

3. Choose the lowest adequate technique

Reduce frames per rotation and mA where image quality permits.
Select low-dose or standard-resolution modes unless high resolution is clinically required.
Use anatomy- and size-specific protocols rather than a single default.
Enable iterative or model-based reconstruction when available to recover image quality at lower dose.

4. Establish and review reference levels

Set protocol-specific reference levels in the platform's native metric, benchmark them against published diagnostic reference levels where they exist, and review outliers. This mirrors the approach used for MDCT in our guide to CT protocol optimization.

Common pitfalls to avoid

Quoting a CTDIvol for a wide cone beam as if it were complete. It understates central dose.
Comparing dental CBCT and MDCT effective doses without matching FOV and technique. The comparison is meaningless without controlling the acquisition.
Ignoring cumulative dose from repeated spins or daily setup imaging. Image-guidance dose adds up.
Treating displayed KAP as an organ dose. It is a kerma-area product, not effective dose.
Skipping platform-appropriate QC because the unit "isn't a real CT." Clinical CBCT needs medical physics oversight.

Regulatory Considerations

CBCT systems sit at the intersection of FDA performance standards for X-ray equipment and state radiation-control requirements for machine-produced radiation, with professional standards from AAPM, the ACR, and IEC defining the technical expectations. X-ray-producing equipment — including CBCT — is regulated by the U.S. Food and Drug Administration under 21 CFR Subchapter J (including the diagnostic X-ray performance standard at 21 CFR 1020.33) and by state radiation-control programs, rather than by the NRC, which governs byproduct (radioactive) material. ⁵

Key frameworks to reference:

AAPM Task Group 111 — the foundational methodology for CT dosimetry that addresses wide-beam and stationary-beam geometries through the equilibrium-dose concept. ¹
AAPM Task Group 261 — guidance specific to CBCT dose and image-quality characterization across platforms.
IEC 60601-2-44 and related IEC standards — define how CT and CBCT dose indices are displayed and measured on equipment.
FDA 21 CFR 1020.33 — diagnostic X-ray performance standard relevant to CT-type equipment. ⁵
NCRP Report No. 160 — population dose context for medical imaging, useful for justification and ALARA discussions. ⁶

In the states DRPS serves — Florida, Maryland, Virginia, California, and Nevada (Agreement States) and Washington, DC (regulated directly by the NRC for materials) — X-ray machine registration, inspection, and physicist-survey requirements are administered under each state's radiation-control rules. Because CBCT can be operated by dental, surgical, interventional, and radiotherapy teams who may not think of it as "CT," it is frequently a gap in registration and QC programs. A qualified physicist evaluation aligns the unit with applicable accreditation support and state requirements, and confirms that displayed dose metrics are properly calibrated.

Frequently Asked Questions (FAQs)

Why does CTDI underestimate cone-beam CT dose?

The standard CTDI chamber is 100 mm long, but many CBCT systems use a beam width far wider than 100 mm. The chamber cannot capture the full scatter tails of a wide beam, so a CTDI measurement misses dose outside the chamber and underreports the true central dose. ¹²

What is the AAPM TG-111 equilibrium-dose method?

AAPM Task Group 111 recommends measuring the approach-to-equilibrium dose with a small thimble or point detector at the center of a long phantom while the beam is delivered. It characterizes the cumulative dose a wide-beam or stationary-beam acquisition deposits, which CTDI cannot represent for wide cone beams. ¹⁴

Is kerma-area product a good dose metric for CBCT?

KAP (also called DAP) is a practical and widely displayed metric for C-arm and dental CBCT. It does not by itself give organ or effective dose, but with validated conversion coefficients it supports patient dose estimation and protocol tracking.

How does dental CBCT dose compare to medical CT?

Dental and maxillofacial CBCT effective doses are generally lower than a comparable MDCT of the same region, but they vary widely with field of view, mA, kVp, and resolution. Small-FOV, low-resolution protocols deliver far less dose than large-FOV, high-resolution protocols.

Does CBCT require medical physics testing and QC?

Yes. Clinically used CBCT should have acceptance testing, periodic performance evaluation, and a routine QC program appropriate to the platform, performed or overseen by a qualified medical physicist.

How can CBCT dose be reduced without losing diagnostic value?

Collimate to the smallest adequate FOV, choose the lowest resolution and frame rate that answers the clinical question, use anatomy- and age-specific protocols, enable iterative or model-based reconstruction, and review reference dose levels periodically.

Who should establish CBCT reference levels for our facility?

A qualified or board-certified medical physicist should help establish protocol-specific reference levels in the platform's native metric, benchmark them against published diagnostic reference levels where available, and integrate them into the facility's quality and radiation safety program.

Key Takeaways

CTDI was built for narrow beams. When the nominal beam width approaches or exceeds 100 mm, CTDIvol truncates the dose profile and understates CBCT central dose. ¹²
TG-111 measures what CTDI cannot. The equilibrium-dose approach captures cumulative central dose for wide and stationary beams; CBDI offers a practical approximation. ¹⁴
KAP/DAP is the native metric for C-arm and dental CBCT — useful for tracking and, with validated coefficients, for dose estimation, but it is not an organ dose.
Field of view is the dominant dose lever. Collimating to the clinical volume reduces dose and often improves image quality.
Cumulative and repeated-exposure dose matters, especially for image guidance, pediatrics, and any potentially pregnant patient.
CBCT needs platform-appropriate physics testing and QC under FDA and state radiation-control frameworks, with proper attention to displayed-metric calibration.

Conclusion

Cone-beam CT delivers enormous clinical value — fast, high-resolution volumetric imaging in interventional suites, dental offices, operating rooms, and radiotherapy vaults. But its defining geometry, a wide cone and an area detector, is precisely what makes the familiar CTDI framework unreliable. A defensible CBCT dose program starts by choosing the right metric for the platform, applies TG-111 or KAP methods where CTDI cannot reach, and then turns those measurements into protocol-specific reference levels and ALARA-driven optimization.

The facilities that handle CBCT well are the ones that stop treating it as "just another CT" and start treating it as a distinct dosimetry problem with its own tools. A qualified medical physicist makes that translation — from raw measurement to clinically meaningful, defensible dose management.

How DRPS Can Help

Diagnostic Radiation Physics Services helps imaging, interventional, dental, and radiotherapy facilities measure and manage CBCT dose correctly. This includes acceptance testing and CT physics testing, platform-appropriate dosimetry using CTDI, TG-111, CBDI, or KAP methods, protocol optimization, reference-level development, calibration verification of displayed dose metrics, and accreditation support — all delivered by board-certified medical physicists.

DRPS supports facilities across Florida, Maryland, Virginia, Washington DC, California, and Nevada. To discuss a CBCT dose evaluation or QC program, contact us or review our service locations.

Related Resources

References

Dixon RL, Boone JM, et al. (AAPM Task Group 111). Comprehensive Methodology for the Evaluation of Radiation Dose in X-Ray Computed Tomography. AAPM Report No. 111. College Park, MD: AAPM; 2010. aapm.org
International Atomic Energy Agency. Status of Computed Tomography Dosimetry for Wide Cone Beam Scanners. IAEA Human Health Reports No. 5. Vienna: IAEA; 2011. iaea.org
Papadakis AE, Damilakis J. Organ doses and normalized organ doses for various age groups in ultralow dose pediatric C-arm cone-beam CT. European Radiology. 2022;32(9):5790-5798. doi:10.1007/s00330-022-08767-7. PubMed
Buckley JG, Wilkinson D, Malaroda A, Metcalfe P. Investigation of the radiation dose from cone-beam CT for image-guided radiotherapy: a comparison of methodologies. Journal of Applied Clinical Medical Physics. 2018;19(1):174-183. doi:10.1002/acm2.12239. PubMed
U.S. Food and Drug Administration. 21 CFR 1020.33: Computed Tomography (CT) Equipment. ecfr.gov
National Council on Radiation Protection and Measurements. Ionizing Radiation Exposure of the Population of the United States. NCRP Report No. 160. Bethesda, MD: NCRP; 2009. ncrponline.org
Haba T, Nishihara Y, Saito Y, et al. Estimating organ dose with optimized peak dose index in cone-beam CT scans. Physica Medica. 2024;118:103215. doi:10.1016/j.ejmp.2024.103215. PubMed
International Commission on Radiological Protection. Radiological Protection in Cone Beam Computed Tomography (CBCT). ICRP Publication 129. Ann ICRP. 2015;44(1). icrp.org
American Association of Physicists in Medicine. The Use of Computed Tomography Dose Index (CTDI) and Wide-Beam Dosimetry. AAPM education and Task Group resources. aapm.org
National Council on Radiation Protection and Measurements. Reference Levels and Achievable Doses in Medical and Dental Imaging. NCRP Report No. 172. Bethesda, MD: NCRP; 2012. ncrponline.org
European Commission (SEDENTEXCT). Radiation Protection No. 172: Cone Beam CT for Dental and Maxillofacial Radiology — Evidence-Based Guidelines. Luxembourg: European Commission; 2012. europa.eu